SynthesisMedicine2017

S-1 monotherapy versus S-1 combination therapy in gemcitabine-refractory advanced pancreatic cancer: A meta-analysis (PRISMA) of randomized control trials.

Sheng Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.